LICENSE AND SERVICES AGREEMENT Between PROTIVA AGRICULTURAL DEVELOPMENT COMPANY INC. on the one hand, and PROTIVA BIOTHERAPEUTICS INC. and TEKMIRA PHARMACEUTICALS CORPORATION, on the other hand Dated: January 12, 2014License and Services Agreement • January 23rd, 2014 • TEKMIRA PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
This License and Services Agreement (this “Agreement”) is entered into as of January 12, 2014 (the “Effective Date”), between Protiva Agricultural Development Company Inc., a British Columbia corporation with a principal place of business at 100-8900 Glenlyon Parkway, Burnaby, B.C., Canada V5J 5J8 (“PadCo”), on the one hand, and Protiva Biotherapeutics, Inc., a British Columbia corporation with a principal place of business at 100-8900 Glenlyon Parkway, Burnaby, B.C., Canada V5J 5J8 (“Protiva”), and Tekmira Pharmaceuticals Corporation, a British Columbia corporation with a principal place of business at 100-8900 Glenlyon Parkway, Burnaby, B.C., Canada V5J 5J8 (“Tekmira”), on the other hand.
PROTIVA-MONSANTO SERVICES AGREEMENTServices Agreement • January 23rd, 2014 • TEKMIRA PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
THIS PROTIVA-MONSANTO SERVICES AGREEMENT (this “Agreement”), effective this January 12, 2014 (hereinafter “Effective Date”), is by and among Protiva Biotherapeutics, Inc., a British Columbia corporation and a wholly-owned subsidiary of Tekmira Pharmaceuticals Corporation, a British Columbia corporation, (“Protiva”), Protiva Agricultural Development Company Inc. (“PadCo”), a British Columbia corporation and a wholly-owned subsidiary of Protiva (the “Company”), and Monsanto Company, a Delaware corporation (“Monsanto”). Protiva, the Company and Monsanto are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
PROTIVA AGRICULTURAL DEVELOPMENT COMPANY INC. OPTION AGREEMENTOption Agreement • January 23rd, 2014 • TEKMIRA PHARMACEUTICALS Corp • Pharmaceutical preparations • New York
This OPTION AGREEMENT (this “Agreement”), made as of January 12, 2014 (the “Effective Date”) by and among Monsanto Canada, Inc., a Canadian corporation (“Monsanto Canada”), Tekmira Pharmaceuticals Corporation, a British Columbia corporation (“Tekmira”), Protiva Biotherapeutics Inc., a British Columbia corporation (“Protiva”), and Protiva Agricultural Development Company Inc., a British Columbia corporation (the “Company”).
